Article
CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
Acta pharmacologica Sinica - 1 Dec 2003
Lin Bo, Zhang Zhen-Lin, Yu Lu-Yang, Guo Li-He
Abstract excerpt
AIM: To investigate the role of Fas-FasL pathway in the pathogenesis of streptozotocin (STZ)-induced type I diabetes mellitus. METHODS: Low dose injections of STZ were used to induce type I diabetes mellitus in the CMV-hFasL transgenic mice. Blood glucose concentration was measured with Glucotrand Plus blood glucose test strips. Expression of hFasL was detected by RT-PCR and Western blotting. The severity of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
